闭合切口负压伤口治疗在非自体乳房手术中的有效性:系统综述与Meta分析
该系统综述与Meta分析纳入20项研究(6项RCT、14项观察性研究),共2287例患者(3376侧乳房),评估预防性闭合切口负压伤口治疗(ciNPWT)对比标准敷料在非自体乳房手术中的效果。结果显示ciNPWT显著降低总伤口并发症(RR 0.56,95%CI 0.42-0.74;p<0.0001;I²=71.9%;中等确定性),绝对风险降低14%(31.8%至17.8%),并显著减少伤口裂开和坏死。
要点
- ciNPWT显著降低非自体乳房手术总伤口并发症风险(RR 0.56,ARR 14%)。
- ciNPWT还显著减少伤口裂开和坏死,对感染、血清肿等无显著影响。
- BMI≥30和-125 mmHg设置下效果可能更强,但亚组差异无统计学意义。
核心结论
- 中等确定性证据表明ciNPWT可降低非自体乳房手术后伤口并发症,尤其伤口裂开和坏死,总伤口并发症绝对风险降低14%。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA,检索至2025年9月,纳入比较ciNPWT与标准敷料的RCT和观察性研究。
- 共纳入20项研究(6项RCT、14项观察性研究),涉及2287例患者(3376侧乳房),行乳房切除术、植入物乳房重建或乳房整形术。
- 使用RoB2和ROBINS-I评估偏倚风险,GRADE评估证据确定性,数据用RStudio合并,PROSPERO注册号CRD420251002005。
主要发现
- ciNPWT显著降低总伤口并发症(RR 0.56,95%CI 0.42-0.74;p<0.0001;I²=71.9%;中等确定性),绝对风险降低14%(31.8%至17.8%)。
- ciNPWT显著降低伤口裂开(RR 0.48,95%CI 0.29-0.79;p=0.0037;I²=33.4%)和坏死(RR 0.67,95%CI 0.48-0.94;p=0.0187;I²=7.5%)。
- 亚组分析提示BMI≥30(RR 0.41 vs 0.61)和-125 mmHg设置(RR 0.46 vs 0.65)下效果更强,但差异无统计学意义(p>0.20)。
临床怎么用
- 可考虑在非自体乳房手术(乳房切除、植入物重建、乳房整形)中预防性使用ciNPWT以减少伤口并发症。
- 对BMI≥30患者或采用-125 mmHg设置时可能获益更大,但需个体化选择。
局限性
- 纳入研究以观察性研究为主(14/20),异质性较高(总伤口并发症I²=71.9%)。
- 亚组分析中BMI和压力设置的差异未达统计学显著性(p>0.20)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prophylactic closed-incision negative pressure wound therapy (ciNPWT) may reduce risk of postoperative wound complications, but its use in breast surgery remains uncertain due to lack of breast-specific recommendations in guidelines. This meta-analysis addresses this gap by evaluating the efficacy of ciNPWT versus standard dressings in non-autologous breast surgery. METHODS: A meta-analysis of RCTs and observational studies comparing ciNPWT versus standard dressings in patients undergoing mastectomy, implant-based breast reconstruction, or mammoplasty was conducted following PRISMA (from inception to September 2025). Outcomes were total wound complications, surgical site infection, wound dehiscence, necrosis, seroma, haematoma, re-operation, and implant loss. Risk of bias (RoB2, ROBINS-I) and certainty (GRADE) were assessed, and data pooled (RStudio). Registered with PROSPERO (CRD420251002005). RESULTS: Twenty studies (6 RCTs, 14 observational) involving 2287 patients (3376 breasts) were included. ciNPWT significantly reduced total wound complications (RR 0.56, 95%CI 0.42-0.74; p<0.0001; I²=71.9%; moderate certainty), corresponding to an absolute risk reduction (ARR) of 14% (31.8% to 17.8%). Wound dehiscence (RR 0.48, 95%CI 0.29-0.79; p=0.0037; I²=33.4%) and necrosis (RR 0.67, 95%CI 0.48-0.94; p=0.0187; I²=7.5%) were also significantly reduced. Subgroup analyses suggested stronger effects in BMI ≥30 (RR 0.41 vs 0.61 for BMI <30) and with -125 mmHg settings (RR 0.46 vs 0.65 for -80 mmHg), though differences were not statistically significant (p>0.20). CONCLUSION: Moderate-certainty evidence indicates that ciNPWT reduces postoperative wound complications-particularly dehiscence and necrosis-with a clinically meaningful ARR of 14% for total wound complications. Refining patient selection and device configuration may further enhance its applicability.
引用
- Nguyen CL, Kaur R, Tam SKM, et al. Effectiveness of Closed-Incision Negative Pressure Wound Therapy in Non-Autologous Breast Surgery: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2026. PMID: 42842697. doi:10.1097/PRS.0000000000013481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。